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It has been reported that curcumin has a hepatoprotective effect, but 
its low solubility limited its utilization. Recently there was so many emerging 
research of advanced curcumin formulation, such as nanoparticles 
curcumin. In our previous study, curcumin has been loaded into mesoporous 
silica nanoparticles (C-MSN). This study was performed to evaluate of C-
MSN hepatoprotective effect in CCl4-induced rats. Sixteen rats were divided 
into four groups, namely normal and CCl4 control, curcumin, C-MSN group. 
Treatment was given according to its group for fourteen days consecutively. 
At day 14, three hours after the last administration, CCl4 (1.25mL/kgBB) 
were administered orally. Twelve hours later the rats were sacrificed, and 
blood samples were drawn from their hearts. Blood serum examination 
result revealed that C-MSN caused a significantly lower ALT and AST than 
CCl4 control group (851±271U/L vs 1734±275U/L; 295±155U/L vs 
1348±235U/L; p<0.05). Its effect on hepatic serum level resembled 
curcumin group. However, the result was not supported by histology 
examination which showed a higher number of necrotic hepatic cells in                 
C-MSN group than in the curcumin group (147±9 vs 80±16; p<0.05). From 
this study, it can be concluded that C-MSN revealed an excellent 
hepatoprotective property, but it was suspected that MSN itself has the toxic 
effect on the liver. A further study of MSN toxicity was needed to support its 
safety use. 





Curcuma longa L. (Zingiberaceae) or 
turmeric is used widely in Indonesia as food spices. 
However, turmeric has potential as a medicine, 
beauty aid, cooking spice, and as a dye (Omosa et 
al., 2017). C. longa contains curcumin, a natural 
polyphenol, and a primary yellow pigment. 
Curcumin is one of the curcuminoids in the 
rhizome that has many activities such as 
hepatoprotective, antioxidant, antineoplastic, anti-
bacterial, antiviral, antifungal, anti-inflammatory, 
antidiabetic, anticoagulant, antifertility, cardio-
vascular protective, and immunostimulant activity. 
Therefore, curcumin is believed as one of the 
constituents responsible for bioactivities of the 
rhizome of this plant.  
 
In several previous studies, C. longa was 
reported to have a hepatoprotective effect against 
CCl4 hepatic damage induction (Girish and 
Pradhan, 2012; Hismiogullari et al., 2014; Kim et 
al., 2014; Lee et al., 2017; Marslin et al., 2018; Paolo 
and Kateri, 2017; Park et al., 2000; Saygili et al., 
2016; Singh et al., 2014; Wu et al., 2008; Zhao et al., 
2014). Fermented C. longa is showing a 
hepatoprotective effect by suppressing oxidative 
stress caused by CCl4 (Kim et al., 2014). C. longa 
(30, 300mg/kg b.w.) given orally for 14 days          
has   inhibited   alanine    aminotransferase   (ALT),  
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aspartate aminotransferase (AST), alkaline 
phosphatase (ALP), and lactate dehydrogenase 
(LDH) (Kim et al., 2014). It also enhanced 
antioxidant activities so that it was suitable as a 
candidate for various liver diseases prevention 
associated with oxidative stress (Kim et al., 2014). 
Aqueous extract of C. longa also reported having 
amelioration property to CCl4-induced 
hepatotoxicity in Swiss albino mice (Sengupta et 
al., 2011). Its methanol extract also showed an 
ameliorating effect on galactosamine-induced liver 
injury in mice (Adaramoye et al., 2010). Its ethanol 
soluble fraction also has been proven to have a 
hepatoprotective effect on tacrine-induced 
cytotoxicity in human liver-derived HepG2 cells 
(Song et al., 2001). Curcumin hepatoprotective 
activities were also evidenced in lipopoly-
saccharide/d-galactosamine model of liver injury 
in rats. It decreases ALT and AST levels as well as 
lipid peroxidation activities (Černý et al., 2011).  
In the clinical setting, the use of curcumin as 
hepatoprotection agent in the patient with liver 
cirrhosis has been a standard clinical treatment in 
an Indonesian hospital. Nowadays, the use of 
curcumin as one of the liver cirrhosis therapy is 
also an increasing trend  (Farida et al., 2013; Tandi, 
2017; Virgonita and Karim, 2012). However, the 
effectiveness of curcumin as a drug is limited by its 
chemical properties. Curcumin has low 
bioavailability because it has negligible solubility 
in water and only limited solubility in ethanol or 
acetone. Some researchers prepare an innovative 
breakthrough by loading curcumin into nano-
particles. Some previous hepatoprotective study 
showed that curcumin nanoparticles also have 
hepatoprotection effect, even better than 
curcumin. Solid lipid nanoparticles loaded with 
curcumin (C-SLN; 12.5mg/kg b.w.) given daily for 
four weeks showing a significant effect as an 
antioxidant and as a protector of liver damage in 
CCl4 subchronic induction. C-SLN has a 62.07 and 
83.37% inhibition of hepatic impairment resulting 
in 2.63 and 6,01 fold alleviation in ALT and AST 
values, respectively (Singh et al., 2014). Curcumin 
also has been loaded in nanoparticles prepared 
from PLGA and PVA was given four times a week 
with CCl4 given two times a week. That curcumin 
nanoparticles showed a good hepatoprotection 
effect as AST, ALT, and ALP value was decreased, 
and no damage was found in liver tissue treated 
with nano-curcumin (Marslin et al., 2018).  
In our previous research curcumin has been 
loaded into mesoporous silica nanoparticles (C-
MSN). It has been proven that C-MSN has a higher 
bioavailability than ‘free curcumin’ (Hartono et al., 
2016) so that it was expected to have a better 
hepatoprotection activity. In the present study, the 
C-MSN hepatoprotective effect will be evaluated 
against curcumin. To best our knowledge, this is 
the first report of cubical curcumin-amine 
functionalized mesoporous silica nanoparticles (C-
MSN) hepatoprotection effect. 
 
MATERIAL AND METHODS 
Sample and chemicals 
Curcuma longa L. dry extract was purchased 
from and certified by Java Plants (Solo, Indonesia). 
C-MSN was prepared according to the method 
described by Hartono et al. (2016). Materials                 
for C-MSN hepatoprotective study are carbon 
tetrachloride (E-Merck, Germany), corn oil (PT. 
Jaya Utama Santika, Indonesia), formaldehyde 
(Sigma Aldrich, Singapore), monosodium and 
disodium phosphate (PT. Labtech Citra Persada, 
Indonesia), alcohol 96% (Sigma Aldrich, 
Singapore), sodium carboxymethylcellulose 0.5% 
as vehicles (Sigma Aldrich, Singapore), sterile 
sodium chloride 0,9% (Otsuka, Indonesia), water 
for injection (Otsuka, Indonesia).  
 
Animals 
Eight until twelve-week-old male Wistar 
rats (Rattus norvegicus) with body weight (b.w.) of 
109-127g were obtained from a veterinarian 
breeder. All animals transferred into the animal 
laboratory in Widya Mandala Catholic University, 
Surabaya, Indonesia to be acclimatized for seven 
days. Rats were housed under 12h light/dark cycle 
and fed with standard laboratory diet and water ad 
libitum. Ethical approval was requested from the 
Animal Ethics Committee at Gadjah Mada 




MSN preparation was done using a method 
published in our previous paper. 0.5g of triblock 
poly(ethylene oxide)-b-poly(propylene oxide)-b-
poly(ethylene oxide) copolymer EO106PO70EO106 
(Pluronic® F127, MW=12600)  and 1.4 of 
fluorocarbon surfactant (FC-4) mixed in the 
solutions of 60mL of 0.02M HCl then 0.5g of           
1,3,5-trimethylbenzene (TMB) was added. 
Tetraethoxysilane (TEOS, 99%) was added after 
four h stirring and continued for 24h at 20°C. The 
substance was heated at 130°C for 24h in an 
autoclave then it was separated, washed and dried. 
Its surfactant was removed by calcination at 550°C 
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for six h. Amine functionalization was performed 
by grafting method where 0.6g of mesoporous 
silica (MSN) was added into 30mL toluene. It was 
stirred and heated to 70°C, and 1.2mL of 3-
aminopropyltriethoxysilane (APTES, 99%) was 
added into the mixture, then the stirring was 
continued for 20h. The substance then centrifuged 
and dried. After the MSN was ready, curcumin was 
loaded into MSN. 50mg of curcumin and 200mg of 
MSN was mixed within a rotary evaporation flask. 
After added 20mL of ethanol, the mixture was 
sonicated for 2min with a Bath sonicator. Ethanol 
was evaporated slowly under vacuum at a 
temperature of 55°C. Finally, curcumin loaded MSN 
was obtained (Hartono et al., 2016). 
 
Experimental groups determination 
The method used in this study refers to the 
hepatoprotective testing method from Kim et al. 
(2014). There were four animal groups in this 
experiment. Each group was consists of four 
animals. The animal was grouped randomly                
with regards to minimalized body weight           
variation within the group. All substances                    
were administered by gastric intubation. The 
administration was done continuously for 14 days 
daily. The curcumin group was administered 
2mg/kg b.w. Curcumin. The C-MSN group was 
administered 10mg/kg b.w. C-MSN. Curcumin and 
C-MSN powder were prepared in mucilage form 
with 0.5% CMC-Na. The normal and CCl4 control 
group rats were administered only 0.5% CMC-Na. 
At day 14, three hours after last administration, 
curcumin, C-MSN, and CCl4 control group were 
administrated CCl4 1.25mL/kg b.w, dissolved in 
20% corn oil. CCl4 was administered using gastric 
intubation method. The control group rats were 
only given 20% corn oil. Rats were anesthetized 
12h after CCl4 treatment under ketamine 40mg/kg 
b.w. and xylazine 7mg/kg b.w. (intraperitoneally) 
to collect the blood sample. After the blood sample 
was taken from the heart, cervical dislocation and 
abdominal incision were performed to collect liver 
from the rats.             
 
Hepatic enzymes analysis        
Blood samples collected from rats were 
centrifuged to separate sera. Sera were prepared 
for analysis according to the manual procedure of 
biochemical autoanalyzer (Prestige 24i Tokyo-
Boeki, Japan). International Federation of Clinical 
Chemistry (IFCC) method was performed to 
determine aspartate aminotransferase (AST), 
alanine aminotransferase (ALT) and alkaline 
phosphatase (ALP) level.  
 
Histology examination of the liver    
All portions of the liver were fixed in 10% 
buffered formalin solution for 24h and then 
trimmed. The liver tissue (n=4/ group) were 
gradually dehydrated in 70% alcohol, 80% alcohol, 
90% alcohol, 96% alcohol, xylol, and liquid 
paraffin. Next step is tissue vacuuming and 
embedding. Liver tissue was sectioned at a 
thickness of 4-6µM and then processed with 
hematoxylin and eosin staining. Tissue was 
observed under a microscope (Olympus CX-21, 
Japan with Optilab® Advanced Plus, Indonesia) 
with 400 times magnification. Five hundred cells 
were counted for each preparation slide, and those 
cells were classified into normal, degenerated, and 
necrotic cells (Amdalia et al., 2017). 
The H&E stained sections were evaluated 
under light microscopy. Five hundred cells were 
counted in five visual fields (from the upper left of 
the to the right direction of preparation). Those 
cells were then classified into normal, degenerated, 
and necrotic cells (including karyopyknotic, 
karyorrhexis, and karyolysis cells) (Amdalia et al., 
2017; Nayak et al., 2016). 
 
Statistical analysis 
ALT, AST, ALP, number of necrotic and 
degenerated liver cells are presented as mean ± SD 
of 4 replicates. All data were statistically analyzed 
using IBM SPSS Statistics for Windows, Version 
24.0 (IBM Corp., USA). After testing the normality 
of the data distribution using a Shapiro-Wilk test, 
one-way analysis of variance (ANOVA) was 
performed. LSD multiple comparisons were 
performed as a post-hoc test to see any significant 
differences between each group.  A 0.05 level was 
adopted for any significant difference.  
 
RESULT AND DISCUSSION 
Carbon tetrachloride (CCl4) induced a very 
significant increase in ALT, AST, ALP (p<0.05), 
namely 29, 9, and two times of normal control 
group value, due to severe damage of the liver cells 
(Table I). This result is in line with the previous 
study result that supports CCl4 as a preferred 
chemical compound to induce animal hepatic cell 
damage. (Girish and Pradhan, 2012; Hismiogullari 
et al., 2014; Y. Kim et al., 2014; Lee et al., 2017; 
Marslin et al., 2018; Paolo and Kateri, 2017; Park et 
al.,  2000;  Saygili  et al.,  2016;  Singh  et  al.,  2014;  
  
Lannie Hadisoewignyo 
Volume 30 Issue 2 (2019)  117 
Wu et al., 2008; Zhao et al., 2014). Hepatic damage 
induction using CCl4 it is easily reproducible, and it 
simulates human liver cirrhosis quite well by the 
generation of oxidative stress and induces 
proinflammatory and profibrotic cytokines. CCl4 is 
converted into CCl3- in the liver. Its exposure to O2 
result in CCl3- transformation to CCl3O2-. CCl3- and 
CCl3O2- are highly reactive to bind to lipid and 
protein. Those radicals could remove a hydrogen 
atom from unsaturated lipids and causes lipid 
peroxidation. All the structural changes caused by 
those free radicals will lead to not only 
endoplasmic reticulum modification but also 
protein synthesis reduction. The cytoplasmic 
membrane lipids damage will eventually cause an 
increase in hepatic serum markers, namely ALT, 
AST, and ALP. Therefore those enzymes utilized as 
biochemical markers for chemicals or drug-
induced liver injury in a clinical setting. Some 
previous study pointed a decrease in those 
enzymes while hepatocurative substance or 
antioxidants were given to CCl4-induced animals 
(Abou Seif, 2016; Manfo et al., 2014; Reyes-
Gordillo et al., 2012). 
 
Effects of C-MSN on a hepatic biochemical 
marker  
ALT, AST, and ALP level in the curcumin 
group were lower than the CCl4 control group 
although the decrease only significant in the ALT 
group (49%, 51%, 4% lower; p<0.05) (Table I). 
Curcumin can reduce oxidative stress, and 
therefore it has a protective effect on the liver. It 
inhibits NF-κB activity, proinflammatory 
cytokines, liver tissue morphology and HSC 
(primary fibrogenic cells in the liver) activation 
(Farzaei et al., 2018). Curcumin has a potential 
counter effect on CCl4 toxicity by preventing  
biliary cirrhosis and also reverse fibrosis that has 
been   recognized.  Fibrogenesis  of  liver  cells  was  
inhibited by lowering TLR2, TLR4, and HMGB1 
expression, inhibiting of proinflammatory 
mediators and HSC activation. Curcumin is also 
reducing the α-smooth muscle actin (a-SMA) 
expression and deposition of collagen to                     
relieve liver fibrosis and necrosis and 
inflammation of the liver. Curcumin also 
significantly attenuates the molecular expression 
of Smad2, phosphorylated Smad2, Smad3, TGF-b, 
and connective tissue growth factor (CTGF). It            
also induced the expression of the Smad7. 
Therefore,   it can be said that curcumin decreases 
fibrosis by inhibiting the TGF-b1/Smad signalling 
pathway and CTGF expression (Reyes-Gordillo et 
al., 2012).  
C-MSN showed a slightly better 
hepatoprotective effect evidenced by lower serum 
ALT (3.2% lower) and AST (55% lower) than the 
curcumin group. Although there is a mixed type of 
hepatic damage, there are two main types of liver 
damage which are hepatocellular (predominantly 
first ALT elevation) and cholestatic (initial ALP 
rise). AST has a catalyzer property to the 
conversion process from alanine to pyruvate and 
glutamate. AST could be an indicator of liver 
damage that causes by viral hepatitis, cardiac 
infarction, and liver injury. Lesser degrees of 
increasing ALT level was shown in such condition; 
therefore ALT is more specific to the liver and 
could be a better parameter for detecting liver 
injury.  
Meanwhile, serum ALP is related to hepatic 
cell function. An increase in serum ALP is due to 
increased synthesis as a result of the increase in 
biliary pressure (Abou Seif, 2016). Although serum 
ALP was not significantly different between 
curcumin and C-MSN group (724±116U/L vs 
819±58U/L; p>0.05), histology of the liver cells 
(Figure 1) showed an excellent protective effect on 
the liver cells.  
 
Table I. Effect of curcumin and C-MSN on hepatic serum markers of CCl4-induced rats. 
 
Group ALT (U/L) AST (U/L) ALP (U/L) 
Normal control 59±2c 153±21b 435±78b 
CCl4 control 1734±275a 1348±235a 754±74a 
Curcumin 879±272b 656±358ab 724±116a 
C-MSN 851±271b 295±155b 819±58a 
 
Data express the mean ± S.E.M for four rats (in units/liter). AST, aspartate aminotransferase; ALT, alanine 
aminotransferase; ALP, alkaline phosphatase. Means sharing a different subscript in a column are significantly different 
(LSD multiple comparison test, p < 0.05). 
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Effects of C-MSN on hepatic histopathological 
morphology  
The histology of liver rat cells in normal 
group showed that the number of necrotic hepatic 
cells and the degenerated cells were lower than the 
other group (Figure 1A). 
CCl4 caused a significant increase in necrotic 
and degenerated cells (Table II). The number of 
necrotic and degenerated cells were 12 and 3.5 
times higher respectively. Various cells showed 
hydropic degeneration with swelling cells, 
cytoplasm filled with clear vacuoles which can be 
composed of fat, water, or glycogen (Figure 1B). 
Those clear vacuoles can push away the cell 
nucleus to the edge. Some cells were showed fatty 
degeneration with swelling cells and clear fat 
vacuoles. Necrotic cells were found dominantly in 
three different types, pyknosis cells, karyorrhexis 
cells, and karyolysis cells. Hepatic lobular 
disorganization was also very obvious. However, 
rats pre-treated with curcumin (Figure 1 C) and C-
MSN (Figure 1D) has a lower number of necrotic 
liver cells (p<0.05). A good hepatoprotective effect 
of C-MSN was in line with our result from the 
previous study that C-MSN has a good release 
profile, a higher solubility, and bioavailability than 
free curcumin. C-MSN has a cubic mesostructure 
and 3D interconnected pores, large pore size, and 
reduced diffusion length. Together with amine 
functionalization, C-MSN has a fast and higher 
release of curcumin in a sustained manner. It has a 
better dissolution rate and a higher bioavailability 
so that it can protect the liver more effectively than 






Figure 1. Histology of liver rat cells in CCl4-induced rats in normal group (A), CCl4 control group (B), 
curcumin group (C), C-MSN group (D) (H&E staining, 400x magnification). 
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A significant decrease in necrotic and 
degenerated cells was found in the curcumin group 
rather than in the C-MSN group. Otherwise, C-MSN 
group turned to have a higher necrotic and 
degenerated cells. It was already known that 
curcumin has an excellent protective effect against 
liver fibrosis by inhibiting HIF-1α through an ERK-
dependent pathway (Marslin et al., 2018). It was 
interesting that C-MSN group showed a higher 
number of necrotic cells compared with curcumin 
group although it was not statistically significant. 
That phenomenon led to the emergence of 
suspicion towards MSN toxicity. It has been 
reported that shapes influenced the toxicity of 
MSN. There was an increase in silica content in the 
liver at seven days after 40mg/kg b.w. spherical 
shape MSN oral administration. This trend was in 
opposition with shot and long rod shape of MSN. 
However, there was no significant increase in 
hepatic enzyme markers or liver histological 
micro-morphology damage at 14 days after 
administration of MSN with various shape. Also, 
renal tubular impairment was found in that study 
(Li et al., 2015). One previous study had been 
reported no toxicity after 90 days oral 
administration of colloidal silica nanoparticles (20 
and 100 nm size) given at 2000mg/kg dose (Kim et 
al., 2014). Another study reporting hepatic toxicity 
with mononuclear infiltrate at the portal area and 
hepatocyte necrosis at the portal triads of the liver 
at 30 days after MSN (10mg/kg) IV administration 
(Xie et al., 2010).  To date, there was no report 
regarding the oral toxicity of cubical MSN used in 
this study. So further study is needed.  
 
CONCLUSION 
C-MSN used in this study showed excellent 
hepatoprotective properties with a significant 
decreasing number of necrotic cells compare with 
CCl4 control group (2.6% lower; p<0.05). C-MSN is 
a promising compound to be formulated as a 
hepatoprotective agent. However, an oral toxicity 
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